Latest Breaking News On - Amit etkin - Page 1 : vimarsana.com

Alto Neuroscience to Present at the Jefferies Global Healthcare Conference

Alto Neuroscience, Inc. today announced that Company management will participate in the Jefferies Global Healthcare Conference, taking place June 5-6, 2024, in New York. Amit Etkin, M.D., Ph.D.,.

New yorkUnited statesAmit etkinAlto neuroscience incAlto neuroscienceJefferies global healthcare conferencePrecision psychiatry platform

Alto Neuroscience Announces Data Presentations Highlighting Late-Stage Clinical Pipeline and Robust Platform at Upcoming Scientific Conferences

Alto Neuroscience Announces Data Presentations Highlighting Late-Stage Clinical Pipeline and Robust Platform at Upcoming Scientific Conferences
marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.

United statesSan franciscoJohn sonnenbergCherise chin fattAdam savitzSamanthav goncalvesNicholasj cooperPeter emmelAdamj savitzGuhan sundarMichael avissarDaniel mathalonGriffin hallBarbara echevarriaMark oplerFaizan badami

Alto Neuroscience (ANRO) Reports Positive Phase 1 Results for ALTO-101

Alto Neuroscience (ANRO) Reports Positive Phase 1 Results for ALTO-101
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Amit etkinAlto neuroscience incAlto neuroscience

Alto Neuroscience Announces Positive Phase 1 Results for ALTO-101, a Novel PDE4 Inhibitor in Development for Schizophrenia

– ALTO-101 demonstrated a favorable pharmacokinetic and tolerability profile; novel transdermal formulation delivered significantly greater drug exposure and fewer adverse events typically.

Amit etkinAlto neuroscience incExchange commissionAlto neurosciencePrecision psychiatry platformPrivate securities litigation reform actAnnual report

Alto Neuroscience Appoints Maha Radhakrishnan, M D , to Board of Directors

– Experienced Medical and Executive Leader, Dr. Radhakrishnan served as Group SVP and Chief Medical Officer of Biogen, responsible for the Worldwide Medical function – .

Maha radhakrishnanAmit etkinPeople friendship universityAlto neuroscience incBioverativ incUnited health groupExchange commissionBristol myers squibbAlto neuroscienceFriendship universityPrecision psychiatry platformPrivate securities litigation reform actFinal prospectusSecurities act